| Date | Title | Description |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently
The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |
| 20.07.2023 | SURGE Therapeutics Lands $32M Series B |
CAMBRIDGE, MA, SURGE Therapeutics, a biotech company pioneering the delivery of immunotherapy during cancer surgery, announced a $32 million Series B funding round.
>> Click here for more funding data on SURGE Therapeutics
>>... |
| 19.07.2023 | Surge Therapeutics Raises $32M in Series B Financing | Surge Therapeutics, a Cambridge, MA-based biotech company advancing the delivery of immunotherapy during cancer surgery, raised $32M in Series B funding.
The round was led by Bioluminescence Ventures, with participation from KdT Ventures, P... |
| 18.10.2022 | SURGE Therapeutics Raises $26M to Accelerate Intraoperative Immunotherapy | What You Should Know:
SURGE Therapeutics (The Intraoperative Immunotherapy Company™) seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed.
While surgery is the standard of... |
| 17.10.2022 | Surge Therapeutics Raises $26M in Series A Funding | Surge Therapeutics, a Cambridge, MA-based biotechnology company, raised $26M in Series A funding.
The round was led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, a... |
| 17.10.2022 | SURGE Therapeutics Inks $26M Series A |
CAMBRIDGE, MA SURGE Therapeutics announced the completion of a $26 million Series A financing led by Camford Capital.
>> Click here for more funding data on SURGE Therapeutics
>> To export SURGE Therapeutics funding data to ... |
| - | SURGE Therapeutics | “SURGE Therapeutics – Focused. Immunotherapy. Delivered.” |
